"10.1371_journal.pone.0126917","plos one","2015-05-19T00:00:00Z","Stephen A Rawlings; Francis Alonzo; Lina Kozhaya; Victor J Torres; Derya Unutmaz","Department of Microbiology, New York University School of Medicine, New York, New York, United States of America; Department of Pathology, New York University School of Medicine, New York, New York, United States of America; Department of Medicine, New York University School of Medicine, New York, New York, United States of America","Conceived and designed the experiments: DU SAR. Performed the experiments: SAR LK. Analyzed the data: SAR DU LK. Contributed reagents/materials/analysis tools: FA VJT. Wrote the paper: SAR DU.","The authors have the following competing interests: FA, VJT and DU are co-inventors on patent applications on LukED toxin, filed by New York University School of Medicine, which are currently under commercial license. The authors would also like to declare that they have a patent application pending on the use of LukED toxin as a potential anti-HIV and inflammatory agent as detailed below. There are no current products developed related to this intellectual property. The authors confirm that this application does not alter their adherence to all PLOS ONE policies on sharing data and materials. U.S. Patent Application Serial No. 14/468,026, filed August 25, 2014, for LEUKOTOXIN E/D AS A NEW ANTI-INFLAMMATORY AGENT AND MICROBICIDEâ€Continuation of U.S. Serial No. 13/527,438, filed June 19, 2012â€Inventors: Torres, et al.","2015","05","Stephen A Rawlings","SAR",5,TRUE,2,2,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
